Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
carmustine (bicnu) (1 trial)
cytarabine (cytosar-u) (1 trial)
etoposide (vepesid) (1 trial)
gen2 (1 trial)
melphalan (alkeran) (1 trial)
sodium oxychloride (1 trial)
olive oil (1 trial)
Carcinoma (Phase 1)
Carcinoma, Hepatocellular (Phase 1)
Dermatitis (Phase 1)
Dermatitis, Atopic (Phase 1)
Eczema (Phase 1)
Multiple Sclerosis (Phase 1)
Sclerosis (Phase 1)
Trials (4 total)
Trial APIs (7 total)